ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "classification criteria"

  • Abstract Number: 2136 • ACR Convergence 2025

    Confirming The Validity Of The New EULAR/ACR Classification Criteria For Pediatric Chronic Nonbacterial Osteomyelitis

    Greta Mastrangelo1, Edan Itzkovitz2, Katherine Sawicka3, Ingrid Goh4, Ari Bitnun5, Sevan Hopyan5, Paul Nathan2, Ronald laxer1 and Brian Feldman1, 1The Hospital for Sick Children, Toronto, ON, Canada, 2The Hospital for Sick Children, Toronto, 3The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada, 4University of Toronto The Hospital for Sick Children, Toronto, ON, Canada, 5The Hospital for Sick Children, Toronto, Canada

    Background/Purpose: Chronic nonbacterial osteomyelitis (CNO) is a noninfectious autoinflammatory bone disease which remains a diagnosis of exclusion, as existing diagnostic criteria are not widely accepted.…
  • Abstract Number: 1672 • ACR Convergence 2025

    Classification criteria, disease phenotypes and long-term outcomes of childhood Sjögren’s Disease into adulthood

    Coziana Ciurtin1, Ruby Gotch2, Hannah Peckham1, Robert Wilson2, Muthana AlObaidi3 and Elizabeth C Jury1, 1University College London, London, United Kingdom, 2University College London Hospital NHS Trust, London, United Kingdom, 3Great Ormond Street Hospital, London, United Kingdom

    Background/Purpose: Childhood Sjögren Disease (cSjD) is a rare clinical phenotype lacking research on long-term outcomes and impact on the quality of life of young people…
  • Abstract Number: 1575 • ACR Convergence 2025

    Clinical presentation, course, treatment and outcome of juvenile onset versus adult onset mixed connective tissue disease patients: a multicenter retrospective cohort.

    Kevin Chevalier1, Brigitte Bader-Meunier2, Isabelle Kone-Paut3, Benjamin Torreau4, Marc Michel5, Bertrand Godeau5, Christian AGARD6, Thomas Papo7, Karim Sacré8, Raphaele Seror9, Xavier Mariette10, Cacoub Patrice11, Ygal Benhamou12, Mathilde Leclercq13, Cécile goujard14, Olivier Lambotte3, Bernard Bonnotte15, Maxime Samson16, Félix Ackermann17, Jean Schmidt18, Pierre Duhaut18, Jean-Emmanuel Kahn19, Thomas Hanslik19, Nathalie Costedoat-Chalumeau20, Benjamin Terrier20, Alexis REGENT21, bertrand Dunogue22, Pascal Cohen23, Véronique Le Guern20, Eric HACHULLA24, Luc Mouthon22 and Benjamin Chaigne22, 1Université Paris Cité, Montrouge, France, 2Necker hospital, Paris, France, 3Bicêtre hospital, Kremlin Bicêtre, France, 4Internal Medicine and Immunology, CHU Tours, Tours, France, 5Henri Mondor hospital, Créteil, France, 6Internal medicine, Nantes University Hospital, Nantes, France, 7Bichat hospital, Paris, France, 8Department of Internal Medicine, Bichat University Hospital, Université Paris Cité, AP-HP, Paris, France, Paris, France, 9Department of Rheumatology, National referral center for auto immune disease and Sjogren disease, Université Paris-Saclay, INSERM UMR1184: Centre for Immunology of Viral Infections and Autoimmune Diseases, Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Le Kremlin Bicêtre, Paris, France., le kremlin bicetre, France, 10Université Paris-Saclay, Le Kremlin Bicetre, France, 11Department of Internal Medicine and Clinical Immunology, Sorbonne Universités, AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Centre national de références Maladies Autoimmunes et systémiques rares, Centre national de références Maladies Autoinflammatoires rares et Amylose inflammatoire (CEREMAIA), INSERM, UMR S959, Immunology-Immunopathology-Immunotherapy (I3), Paris, France, Paris, France, 12Internal Medicine, CHU Rouen, Rouen, France, 13Rouen hospital, Rouen, France, 14Université Paris Saclay, Department of Internal Medicine and Clinical Immunology, Bicêtre Hospital, APHP, UMR1184 Inserm, CEA, Le Kremlin Bicêtre, France, Kremlin Bicêtre, France, 15Internal medicine and clinical immunology, Université Bourgogne Europe , CHU Dijon Bourgogne, Dijon, France, 16CHU Dijon Bourgogne, Dijon, France, 17Foch hospital, Suresnes, France, 18Amiens hospital, Amiens, France, 19Ambroise Paré hospital, Boulogne, France, 20Cochin hospital, Paris, France, 21Hopital Cochin, Paris, France, 22Department of Internal Medicine, National Referral Center for Rare Systemic Autoimmune Diseases, Cochin University Hospital, Université Paris Cité, AP-HP, Paris, France, 23Department of Internal Medicine, National Referral Center for Rare Systemic Autoimmune Diseases, Hospital Cochin, Paris, France, 24CHU Lille, Département de Médecine Interne et Immunologie Clinique, Centre de Référence des Maladies Auto-Immunes et Auto-Inflammatoires Rares du Nord, Nord-Ouest, Méditerranée et Guadeloupe (CeRAINOM), Lille, France, Lille, France

    Background/Purpose: Mixed connective tissue disease (MCTD) is an entity defined by clinical features of differentiated connective tissue diseases (dCTD), such as systemic lupus erythematosus (SLE),…
  • Abstract Number: 1388 • ACR Convergence 2025

    Positive predictive value of various diagnostic codes for the classification of primary Sjӧgren’s syndrome

    Kaci Clement1, Cynthia Crowson2, sarah Achenbach1, Elena myasoedova1, eva carmona3, Robert Vassallo1, Vanessa Kronzer1 and elena Joerns3, 1Mayo Clinic, Rochester, MN, 2Mayo Clinic, Stewartvillle, MN, 3Mayo Clinic, Rochester

    Background/Purpose: Primary Sjӧgren’s syndrome is a multisystem autoimmune disorder characterized by progressive dysfunction of exocrine glands leading to symptoms of keratoconjunctivitis and xerostomia. There is…
  • Abstract Number: 1136 • ACR Convergence 2025

    The Impact of Iron Overload and HFE Genetic Mutations on Joint Disease in Haemochromatosis: Data from the Haemochromatosis Arthropathy Inception Cohorts

    Bayram Farisogullari1, Pedro Machado2, Stephanie Finzel3, Graeme Carroll4, Geraldine mcCarthy5, John Stack6, Simone Parisi7, Graca Porto8, richette pascal9, Gyorgy Nagy10, Marton Weidl10, Ann Rosenthal11, Pascal Guggenbuhl12, Katarzyna Banaszkiewicz13, Barbara Butzeck14, Howard Don15, Svenja Engelhardt16, Jeremy Shearman17, David Mitchell18, Jane Barker19, Valerie Brueton19, Philip Coathup19, Jacquie Dowsett19, Marie Duncan19, Tracey Dunleavy19, Ian Fish19, Allin Hoggarth19, Mark McKinnon19, James Minter19, Tim Osborne19, Marguerite Smith19, Christine Wright19 and Patrick Kiely20, 1University College London, London, 2Department of Rheumatology, University College London, and Department of Rheumatology, Northwick Park Hospital, London North West University Healthcare NHS Trust, Centre for Rheumatology & Department of Neuromuscular Diseases, University College London, London, United Kingdom, 3Department of Rheumatology and Clinical Immunology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany, 4Fiona Stanley Hospital, Perth, Western Australia, Australia, 5Mater Misericordiae University Hospital, Dublin, Ireland, 6Mater Misericordiae University Hospital, Dublin, Dublin, Ireland, 7Ospedaliera Universitaria Città della Salute e della Scienza di Torino, Turin, Italy, 8Centro Hospitalar Universitário de Santo António, Unidade Local de Saúde de Santo António, Porto, Portugal, 9Rheumatology Department, Lariboisiere Hospital, Paris, Ile-de-France, France, 10Buda Hospital of the Hospitaller Order of Saint John of God, Budapest, Hungary, 11Department of Medicine, Division of Rheumatology, Medical College of Wisconsin, Wisconsin, 12Rennes University Hospital, Rennes, France, 13University Clinical Center in Gdańsk, Smoluchowskiego 17 Street, 80-952 Gdańsk, Poland., Gdańsk, Poland, 14European Federation of Associations of Patients with Haemochromatosis,, Croissy-sur-Seine, France, 15Haemochromatosis International, Barnstaple, United Kingdom, 16University of Freiburg, Freiburg im Breisgau, Germany, 17South Warwickshire University Foundation Trust and Warwick Medical School,, Warwick, United Kingdom, 18Clongriffin Medical Centre, Dublin, Ireland, 19c/o St George's University Hospitals NHS Trust, London, United Kingdom, 20St George's University Hospitals NHS Foundation Trust, London, United Kingdom

    Background/Purpose: A EULAR task force developed classification criteria (CC) for Haemochromatosis Arthropathy (HA) using a cohort of people with the C282Y homozygous mutation and arthropathy…
  • Abstract Number: 0607 • ACR Convergence 2025

    Age at Diagnosis of SLE has Increased in a United States Longitudinal Cohort

    Daniel Goldman1, Andrea Fava2, Laurence Magder3 and Michelle Petri1, 1Johns Hopkins University School of Medicine, Timonium, MD, 2Johns Hopkins University, Baltimore, MD, 3University of Maryland, Baltimore, Baltimore, MD

    Background/Purpose: The demographics of our lupus cohort have shifted over the decades towards an older population. While much of the shift can be attributed to…
  • Abstract Number: 0854 • ACR Convergence 2025

    The Assessments in Spondyloarthritis International Society (ASAS) and Spondyloarthritis Research and Treatment Network (SPARTAN) Revised Classification Criteria for Axial Spondyloarthritis: Development and Validation in the Classification of Axial SpA Inception Cohort Study

    Walter P. Maksymowych1, Désirée van der Heijde2, Liron Caplan3, Robert Landewé4, Lianne S. Gensler5, Pedro Machado6, Alexandre Sepriano7, Floris A. van Gaalen2, Miranda van Lunteren2, Ben Vandermeer8, Servet Akar9, Sibel Aydin10, Xenofon Barliakos11, Wilson bautista molano12, Stephanie Bernard13, RUBEN BURGOS-VARGAS14, John Carrino15, Alberto Cauli16, Jonathan Chan17, Abhijeet Danve18, Torsten Diekhoff19, Maxime Dougados20, iris Eshed21, Warren Fong22, Rodrigo García Salinas23, Hildrun Haibel24, Nigil Haroon25, Kay-Geert Hermann26, Lennart Jans27, Anne Jurik28, Uta Kiltz29, Tae-Jong Kim30, Robert G. W. Lambert31, Clementina López Medina32, Ennio Lubrano33, Marina Magrey34, Vikas Majithia35, Helena Marzo-Ortega36, Philip J. Mease37, Victoria Navarro-Compan38, John O'Neill39, Mikkel Ostergaard40, Salih Ozgocmen41, Susanne Pedersen42, Fernando Pimentel-Santos43, Denis Poddubnyy44, Fabian Proft45, Sofia Ramiro46, Monique Reijnierse47 and John Reveille48, 1Department of Medicine, University of Alberta, 568 Heritage Building, Edmonton, AB, Canada, 2Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 3Medicine Service, Rocky Mountain Regional VAMC, Aurora, CO, 4Department of Rheumatology, Amsterdam University Medical Center, Amsterdam, Netherlands; and Zuyderland Medical Center, Heerlen, Netherlands, 5Department of Medicine/Rheumatology, University of California, San Francisco, San Francisco, CA, 6Department of Rheumatology, University College London, and Department of Rheumatology, Northwick Park Hospital, London North West University Healthcare NHS Trust, Centre for Rheumatology & Department of Neuromuscular Diseases, University College London, London, United Kingdom, 7Department of Rheumatology, Leiden University Medical Centre, Portela Loures, Portugal, 8Department of Medicine, University of Alberta, Edmonton, AB, Canada, 9Department of Medicine, Izmir Katip Çelebi University School of Medicine, Izmir, Turkey, 10Department of Medicine, University of Ottawa, The Ottawa Hospital Research Institute, Ottawa, ON, Canada, 11Ruhr-University Bochum, Rheumazentrum Ruhrgebiet, Herne, Germany, 12University Hospital Fundacion Santa Fe de Bogota, Bogota, Colombia, 13Department of Radiology, Brooke Army Medical Center, Fort Sam Houston, TX, 14Department of Rheumatology, Hospital General de Mexico, Faculty of Medicine, Universidad Nacional Autonoma de Mexico, Ciudad de México, Mexico, 15Department of Radiology and Imaging, Hospital for Special Surgery, New York, NY, 16Rheumatology Unit, Department of Medicine and Public Health, AOU and University of Cagliari, Cagliari, Italy, 17Department of Medicine, University of British Columbia, Vancouver, BC, Canada, 18Section of Rheumatology, Department of Medicine, Yale School of Medicine, New Haven, CT, 19Department of Radiology, Immanuel Clinic Ruedersdorf, Brandenburg Medical School, Ruedersdorf, Germany, 20Department of Medicine, Hopital Cochin, Universite de Paris, Paris, France, 21Department of Diagnostic Imaging, Sheba Medical Center, Tel Hashomer affiliated with School of Medicine, Tel Aviv University, Tel Aviv, Israel, 22Department of Medicine, Singapore General Hospital, Singapore, Singapore, 23Hospital Italiano La Plata, La Plata, Argentina, 24Charite- University Medicine Berlin Campus Benjamin Franklin, Berlin, Germany, 25Department of Medicine/Rheumatology, University Health Network, Schroeder Arthritis Institute, University of Toronto, Toronto, ON, Canada, 26Department of Radiology, Charité – Universitätsmedizin Berlin, Berlin, Germany, 27Department of Radiology, Ghent University Hospital, Ghent, Belgium, 28Department of Radiology, Aarhus University Hospital, Aarhus, Denmark, 29Rheumazentrum Ruhrgebiet Herne, Ruhr-University Bochum, Herne, Germany, 30Department of Medicine, Chonnam National University Hospital, Seoul, Republic of Korea, 31University of Alberta, Department of Radiology & Diagnostic Imaging, Edmonton, AB, Canada, 32Department of Medicine, Hospital Universitario Reina Sofia, University of Cordoba, IMIBIC, Cordoba, Spain, 33Department of Medicine, Università deglia Studi del Molise, CAMPOBASSO, Italy, 34Case Western Reserve University School of Medicine/University Hospitals Cleveland, Richfield, OH, 35Mayo Clinic Hospital, Jacksonville, FL, 36NIHR Leeds Biomedical Research Centre, The Leeds Teaching Hospitals NHS Trust and Leeds Institute of Rheumatic and Musculoskeletal Medicine (LIRMM), University of Leeds, Leeds, United Kingdom, 37Department of Rheumatology, Providence-Swedish Medical Center and University of Washington, Seattle, WA, 38Department of Rheumatology, La Paz University Hospital, IdiPaz, Madrid, Spain, 39Department of Radiology, McMaster University, Hamilton, ON, Canada, 40Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark, and Copenhagen Center for Arthritis Research, Center for Rheumatology, Rigshospitalet, Glostrup, Denmark, 41Department of Rheumatology, Istinye University/Faculty of Medicine, Istanbul, Turkey, 42Department of Medicine, Rigshopital, University of Copenhagen, Copenhagen, Denmark, 43NOVA Medical School, Universidade NOVA e Lisboa, Lisboa, Portugal, 44Division of Rheumatology, Department of Medicine, University Health Network and University of Toronto, Toronto, Ontario, Canada, and Department of Gastroenterology, Infectious Diseases and Rheumatology, Charité – Universitätsmedizin Berlin, Berlin, Germany; Department of Epidemiology, German Rheumatism Research Centre, Berlin, Germany, 45Department of Gastroenterology, Infectiology and Rheumatology (including Nutrition Medicine), Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany, 46Leiden University Medical Center, Bunde, Netherlands, 47Department of Radiology, Leiden University Medical Center, Leiden, Netherlands, 48Department of Medicine, University of Texas Medical Center, Houston, TX

    Background/Purpose: The 2009 ASAS classification criteria had sensitivity (Sn) of 83% and specificity (Sp) of 84% for a rheumatologist diagnosis of axial spondyloarthritis (axSpA). Given…
  • Abstract Number: 0764 • ACR Convergence 2025

    Frequency of large vessel vasculitis in giant cell arteritis with and without adventiitis of temporal artery – Is the presence of temporal arteritis sufficient to diagnose giant cell arteritis?-

    Yoichiro Akiyama, Jun Nakamura, Ayako Kokuzawa, Hiroi Kusaka, Sho Tani, Fuminori Taniguchi, Kohei Morikawa, Haruka Kondo, Shotaro Yamamoto, Yasuyuki Kamata and Kojiro Sato, Jichi Medical University, Shimotsuke, Tochigi, Japan

    Background/Purpose: Takayasu arteritis (TAK) and giant cell arteritis (GCA) belong to the large vessel vasculitis group. Differences between the two diseases have been reported based…
  • Abstract Number: 0390 • ACR Convergence 2025

    Radiographic Assessment in Juvenile Spondyloarthritis: Evaluating the axJSpA Criteria Using Radiographs Alone Versus MRI

    David M. Biko1, Nancy A. Chauvin2, Michael Francavilla3, Nele Herregods4, Walter P. Maksymowych5, Robert G. W. Lambert6, Timothy Brandon1, Ozgur Kasapcopur7, Mehmet YILDIZ8, Hemalatha Srinivasalu9 and Pamela Weiss10, 1Children's Hospital of Philadelphia, Philadelphia, PA, 2The Cleveland Clinic, Hummelstown, PA, 3Department of Pediatric Radiology, Children’s Hospital Philadelphia, Philadelphia, PA, 4Ghent University Hospital, Ghent, Belgium, 5Department of Medicine, University of Alberta, 568 Heritage Building, Edmonton, AB, Canada, 6University of Alberta, Department of Radiology & Diagnostic Imaging, Edmonton, AB, Canada, 7Istanbul University-Cerrahpasa, Cerrahpasa Medical School, istanbul, Turkey, 8Istanbul University-Cerrahpasa Department of Pediatric Rheumatology, Istanbul, Turkey, 9Children's National Hospital, Washington, DC, 10Childrens Hospital of Philadelphia, Philadelphia, PA

    Background/Purpose: Radiographs are neither sensitive nor reliable for assessing axial disease in juvenile spondyloarthritis (JSpA), though they are still used in some settings due to…
  • Abstract Number: 0389 • ACR Convergence 2025

    An International Delphi Survey for the Definition of New Classification Criteria for Juvenile Idiopathic Arthritis

    Alessandra Alongi1, Hermine Brunner2, Angelo Ravelli3, Tadej Avcin4, Michael Beresford5, RUBEN BURGOS-VARGAS6, Ruben Cuttica7, Raju Khubchandani8, Ronald laxer9, Seza Özen10, Ross Petty11, Carol Wallace12, Nico Wulffraat13, Silvia Magni-Manzoni14, Marija Jelusic15, Alessandro Consolaro16, Jordi anton17, Gerd Horneff18, Mia Glerup19, Giovanni Filocamo20, Gabriele Simonini21, ADELE CIVINO22, Agustin Remesal23, Silvia Scala24, Angela Pistorio25, Daniel Lovell2, Alberto Martini26 and Nicolino Ruperto27, 1Università Milano Bicocca, Milan, Italy, Milano, Italy, 2Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 3IRCCS Istituto Giannina Gaslini, Genoa, Italy, Genoa, Genoa, Italy, 4University Children's Hospital, University Medical Center Ljubljana, Ljubljana, Slovenia, 5Alder Hey Children's NHS Foundation Trust Hospital, Department of Women's & Children's Health, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, United Kingdom, 6Department of Rheumatology, Hospital General de Mexico, Faculty of Medicine, Universidad Nacional Autonoma de Mexico, Ciudad de México, Mexico, 7Hospital Pedro de Elizalde, Buenos Aires, Argentina, 8Jaslok Hospital and Research Center, Mumbai, India, 9The Hospital for Sick Children, Toronto, ON, Canada, 10Hacettepe University Medical Faculty, Ankara, Turkey, 11British Columbia Children’s Hospital, University of British Columbia, Vancouver, ON, Canada, 12Seattle Children's Hospital, University of Washington, Seattle, WA, 13Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, Netherlands, 14Bambino Gesù IRCCS Children's Hospital, Rome, Italy, 15University Hospital Centre Zagreb, Zagreb, Croatia, 16IRCCS Istituto Giannina Gaslini, Genoa, Italy, 17Hospital Sant Joan de Düu. Universitat de Barcelona, Barcelona, Spain, 18Asklepios Klinik, Hamburg, Germany, 19Department of Paediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark, 20Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy, 21Rheumatology Unit, ERN-ReCONNET center, Meyer Children's Hospital IRCCS, Firenze, Firenze, Italy, 22Department of Pediatric Immunology and Rheumatology, LECCE, Italy, 23Hospital Universitario La Paz, Madrid, Spain, 24Clinica Pediatrica e Reumatologia, IRCCS Istituto Giannina Gaslini, Genoa, Italy, 25Servizio di Epidemiologia e Biostatistica, IRCCS Istituto Giannina Gaslini, Genoa, Italy, 26Università degli Studi di Genova, IRCCS Istituto Giannina Gaslini, Genoa, Italy, 27Université Milano Bicocca and Fondazione IRCSS S. Gerardo dei Tintori, Monza, Monza and Brianza, Italy

    Background/Purpose: To improve the current classification criteria for juvenile idiopathic arthritis (JIA), a multi-step initiative coordinated by PRINTO was launched in 2015, starting with a…
  • Abstract Number: 2651 • ACR Convergence 2025

    Development and Validation of the Scleroderma Clinical Trials Consortium Classification Criteria for Systemic Sclerosis Heart Involvement

    Laura Ross1, Andrew Burns2, Andre La Gerche3, Dylan Hansen4, Gerry Coghlan5, Wendy Stevens6, David Prior7, Alan Pham8, Penelope McKelvie4, Chiara Bellocchi9, Yolanda Braun Moscovici10, Cosimo Bruni11, Patricia E. Carreira12, Tracy Frech13, Sabrina Hoa14, Marie Hudson15, Vivien Hsu16, Marco Matucci-Cerinic17, Benjamin Medina Fonseca18, Andrea Low19, Sue-Ann Ng19, Tatiana Rodriguez-Reyna20, Joanne Sahhar21, Mohamed Talaat22, Susanna Proudman23, Alessandra Vacca24, Murray Baron25 and Mandana Nikpour26, 1The University of Melbourne, Melbourne, Victoria, Australia, 2St Vincent's Hospital Melbourne, Fitzroy, Australia, 3St Vincent's Institute of Medical Research, Melbourne, Victoria, Australia, 4St Vincent's Hospital Melbourne, Melbourne, Victoria, Australia, 5Royal Free Hospital, London, United Kingdom, 6St Vincent's Hospital Melbourne & University of Melbourne, Fitzroy, Australia, 7University of Melbourne, Parkville, Australia, 8Alfred Hospital, Melbourne, Australia, 9University of Milan, Milan, Italy, 10Rambam Heath Care Campus, Haifa, Israel, 11Department of Rheumatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland, 12Hospital Universitario 12 de Octubre, Madrid, Spain, 13Vanderbilt University Medical Center, Nashville, TN, 14University of Montreal, Brossard, QC, Canada, 15McGill University, Montréal, QC, Canada, 16Rutgers- RWJ Medical School, South Plainfield, NJ, 17University San Raffaele Milano, Milano, Milan, Italy, 18Universidad Nacional Autonoma de Mexico, Monterry, Mexico, 19Singapore General Hospital, Singapore, Singapore, 20Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico, 21Monash Health, Melbourne, Victoria, Australia, 22Augusta Health, Charlottesville, VA, 23Royal Adelaide Hospital and University of Adelaide, Medindie, South Australia, Australia, 24University and AOU of Cagliari, Monserrato, Italy, 25McGill University, Montreal, Canada, 26University of Sydney, School of Public Health, Faculty of Medicine and Health, Sydney, New South Wales, Australia; St Vincent’s Hospital Melbourne, Department of Rheumatology, Fitzroy, Victoria, Australia, Melbourne, Victoria, Australia

    Background/Purpose: Systemic sclerosis (SSc) heart involvement (SHI) is a serious disease manifestation associated with high mortality. This study presents newly developed classification criteria to enable…
  • Abstract Number: 0272 • ACR Convergence 2025

    Ocular Involvement in Behçet’s Disease: Comparative Study of Two Classification Criteria in Clinical Practice

    Rafael Gálvez Sánchez1, José Luis Martín-Varillas2, Lara Sánchez Bilbao3, Ivan Ferraz Amaro4, Elena Aurrecoechea5 and Ricardo Blanco3, 1Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Immunopathology Group, Santander , Spain, Santander, Spain, 2Rheumatology Division, Hospital de Laredo. IDIVAL, Immunopathology Group. Santander, Spain., Laredo, Spain, 3Rheumatology Division, Hospital Universitario Marqués de Valdecilla, IDIVAL, Immunopathology Group, Santander, Spain, Santander, Cantabria, Spain, 4Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain, 5Hospital Sierrallana, CANTABRIA, Spain

    Background/Purpose: Ocular involvement is a potential severe complication of Behçet’s Disease (BD). The traditional classification, by the International Study Group (ISG, 1990) requires the mandatory…
  • Abstract Number: 2538 • ACR Convergence 2025

    Comparative Study of Two Classification Criteria Sets in Real Clinical Practice in Behçet’s Disease

    Rafael Gálvez Sánchez1, José Luis Martín-Varillas2, Lara Sánchez Bilbao3, Ivan Ferraz Amaro4, Carmen Lasa Teja5, Elena Aurrecoechea6, Diana Prieto-Peña7 and Ricardo Blanco3, 1Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Immunopathology Group, Santander , Spain, Santander, Spain, 2Rheumatology Division, Hospital de Laredo. IDIVAL, Immunopathology Group. Santander, Spain., Laredo, Spain, 3Rheumatology Division, Hospital Universitario Marqués de Valdecilla, IDIVAL, Immunopathology Group, Santander, Spain, Santander, Cantabria, Spain, 4Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain, 5Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Immunopathology Group, Santander, Spain., Riotuerto, Cantabria, Spain, 6Hospital Sierrallana, CANTABRIA, Spain, 7Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Immunopathology Group, Santander, Spain., Santander, Spain

    Background/Purpose: Behçet´s Disease (BD) was traditionally classified according to the International Study Group (ISG) in which oral ulcers were mandatory. International Team for the Revision…
  • Abstract Number: 0270 • ACR Convergence 2025

    Diagnostic Challenge of IgG4-related Disease: Comparison Between ACR/EULAR, Umehara, and Okazaki Criteria

    Rafael Gálvez Sánchez1, Ivan Ferraz Amaro2, Fernando Lopez Gutierrez3, Javier Loricera4, Pablo Martínez Calabuig5, Jorge Juan Fragío Gil6, Roxana González Mazarí7, Cristina Hormigos Martín8, DALIFER FREITES9, Maria Rodríguez Laguna8, Patricia Moya Alvarado10, Marta López I Gómez11, Hector Corominas Macia10, Maite Silva Díaz12, Guillermo González Arribas12, Angel García Aparicio13, Judit Font-Urgelles14, Ivette Casafont Solé15, Elisabet Castaneda16, Carolina Merino Argumánez17, Raquel Zas Vaamonde18, Juan Molina Collada19, Sergio Rodríguez Montero20, Rafael Melero Gonzalez21, Eva Galíndez Agirregoikoa22, Andrea Hernández23, Lucia Pantoja Zarza24, Ignacio Braña Abascal25, Vega Jovaní26, Elia Valls Pascual27, Natalia Mena Vázquez28, ADELA MARIA GALLEGO FLORES29, Noelia Cabaleiro Raña30, Raúl Veroz González31, Mariano Andrés32, Santos Castañeda Sainz33 and Ricardo Blanco34, 1Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Immunopathology Group, Santander , Spain, Santander, Spain, 2Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain, 3Hospital Universitario Marqués de Valdecilla, Immunopathology Group -IDIVAL, Reumatología, Santander, Santander, Spain, 4Hospital Universitario Marqués de Valdecilla, IDIVAL, Immunopathology Group, Santander , Spain, Santander, Spain, 5Hospital General Universitario de Valencia, Spain/ Uversidad Catolica de Valencia San Vicente Martir, Valencia, Spain, Ontinyent, Spain, 6Hospital General Universitario, Valencia, Spain, 7Hospital General Universitario de Valencia, Reumatología, Valencia, Valencia, Spain, 8Hospital Clínico San Carlos, Reumatología, Madrid, Madrid, Spain, 9Rheumatology Service, San Carlos Clinical Hospital, Madrid, Madrid, Spain, 10Hospital de Sant Pau, Reumatología, Barcelona, Barcelona, Spain, 11Hospital Universitario de Araba, Reumatología, Vitoria,, Vitoria, Spain, 12Complejo Hospitalario Universitario de A Coruña, Reumatología, A Coruña, Spain, 13Hospital Universitario de Toledo, Reumatología, Toledo, Toledo, Spain, 14Hospital Universitari Germans Trias i Pujol, Badalona, Spain, 15Hospital German Trias i Pujol, Reumatología, Badalona, Badalona, Spain, 16Hospital Universitario Infanta Sofía, Reumatología, Madrid, Madrid, Spain, 17Hospital Universitario Puerta del Hierro, Reumatología, Madrid, Madrid, Spain, 18Hospital Universitario 12 de Octubre, Reumatología, Madrid, Madrid, Spain, 19Hospital General Universitario Gregorio Marañón, Reumatología, Madrid, Madrid, Spain, 20Hospital Universitario de Valme, Reumatología, Sevilla, Sevilla, Spain, 21Hospital Alvaro Cunqueiro, Reumatología, Vigo, Vigo, Spain, 22BASURTO UNIVERSITY HOSPITAL, BILBAO, Spain, 23Hospital Universitario de Gran Canaria Dr Negrin, Reumatología, Palmas de Gran Canaria, Gran Canaria, Spain, 24Hospital General de Segovia, Reumatología, Segovia, Segovia, Spain, 25Hospital Universitario Central de Asturias, Reumatología, Oviedo, Oviedo, Spain, 26Hospital General Universitario de Alicante, Reumatología, Alicante, Alicante, Comunidad Valenciana, Spain, 27Hospital General de Valencia, Reumatología, Valencia, Valencia, Spain, 28Hospital Regional Universitario de Málaga, Reumatología, Málaga, Malaga, Spain, 29Complejo Hospitalario don Benito Villanueva, Reumatología, Badajoz, Badajoz, Extremadura, Spain, 30Hospital Universitario Montecelo, Reumatología, Pontevedra, Pontevedra, Spain, 31Hospital de Mérida, Reumatología, Mérida, Mérida, Spain, 32Hospital General Universitario de Alicante, Reumatología, Alicante, Alicante, Spain, 33Hospital Universitario La Princesa, Reumatología, Madrid Grupo de cooperación nacional de enfermedad relacionada con IgG4: Blanca García Magallón (Hospital Universitario Puerta del Hierro), Maite Odriozola Gil (Hospital Universitario de Valme), Cristina Arciniega (Hospital de Mérida), Maria Lourdes Mateo Soria (Hospital German Trias i Pujol), Santiago Muñoz (Hospital Universitario Infanta Sofía), Iñigo Jesús Rua Figueroa, (Hospital Universitario de Gran Canaria Dr Negrin), Sabela Fernández Aguado, (Hospital de Montecelo)., Madrid, Spain, 34Rheumatology Division, Hospital Universitario Marqués de Valdecilla, IDIVAL, Immunopathology Group, Santander, Spain, Santander, Cantabria, Spain

    Background/Purpose: IgG4-related disease (IgG4-RD) is a rare immune-mediated condition characterized by fibro-sclerosing inflammation, elevated serum and tissue IgG4 levels, and heterogeneous clinical manifestations. Several classification…
  • Abstract Number: 2489 • ACR Convergence 2025

    Unraveling IPAF, VEDOSS and connective tissue diseases classifications through the mixed connective tissue disease spectrum

    Kevin Chevalier1, Benjamin Torreau2, Marc Michel3, Bertrand Godeau3, Christian AGARD4, Thomas Papo5, Karim Sacré6, Brigitte Bader-Meunier7, Raphaele Seror8, Xavier Mariette9, Cacoub Patrice10, Ygal Benhamou11, Hervé Levesque12, Cécile goujard13, Olivier Lambotte14, Bernard Bonnotte15, Maxime Samson16, Félix Ackermann17, Jean Schmidt18, Pierre Duhaut18, Isabelle Kone-Paut14, Jean-Emmanuel Kahn19, Thomas Hanslik19, Nathalie Costedoat-Chalumeau20, Benjamin Terrier20, Alexis REGENT21, bertrand Dunogue22, Pascal Cohen23, Véronique Le Guern20, Eric HACHULLA24, Benjamin Chaigne22 and Luc Mouthon22, 1Université Paris Cité, Montrouge, France, 2Internal Medicine and Immunology, CHU Tours, Tours, France, 3Henri Mondor hospital, Créteil, France, 4Internal medicine, Nantes University Hospital, Nantes, France, 5Bichat hospital, Paris, France, 6Department of Internal Medicine, Bichat University Hospital, Université Paris Cité, AP-HP, Paris, France, Paris, France, 7Necker hospital, Paris, France, 8Department of Rheumatology, National referral center for auto immune disease and Sjogren disease, Université Paris-Saclay, INSERM UMR1184: Centre for Immunology of Viral Infections and Autoimmune Diseases, Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Le Kremlin Bicêtre, Paris, France., le kremlin bicetre, France, 9Université Paris-Saclay, Le Kremlin Bicetre, France, 10Department of Internal Medicine and Clinical Immunology, Sorbonne Universités, AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Centre national de références Maladies Autoimmunes et systémiques rares, Centre national de références Maladies Autoinflammatoires rares et Amylose inflammatoire (CEREMAIA), INSERM, UMR S959, Immunology-Immunopathology-Immunotherapy (I3), Paris, France, Paris, France, 11Internal Medicine, CHU Rouen, Rouen, France, 12Rouen hospital, Rouen, France, 13Université Paris Saclay, Department of Internal Medicine and Clinical Immunology, Bicêtre Hospital, APHP, UMR1184 Inserm, CEA, Le Kremlin Bicêtre, France, Kremlin Bicêtre, France, 14Bicêtre hospital, Kremlin Bicêtre, France, 15Internal medicine and clinical immunology, Université Bourgogne Europe , CHU Dijon Bourgogne, Dijon, France, 16CHU Dijon Bourgogne, Dijon, France, 17Foch hospital, Suresnes, France, 18Amiens hospital, Amiens, France, 19Ambroise Paré hospital, Boulogne, France, 20Cochin hospital, Paris, France, 21Hopital Cochin, Paris, France, 22Department of Internal Medicine, National Referral Center for Rare Systemic Autoimmune Diseases, Cochin University Hospital, Université Paris Cité, AP-HP, Paris, France, 23Department of Internal Medicine, National Referral Center for Rare Systemic Autoimmune Diseases, Hospital Cochin, Paris, France, 24CHU Lille, Département de Médecine Interne et Immunologie Clinique, Centre de Référence des Maladies Auto-Immunes et Auto-Inflammatoires Rares du Nord, Nord-Ouest, Méditerranée et Guadeloupe (CeRAINOM), Lille, France, Lille, France

    Background/Purpose: Mixed connective tissue disease (MCTD) is a rare systemic disorder that belongs to connective tissue diseases (CTD). Approximately 25% of MCTD patients will meet…
  • 1
  • 2
  • 3
  • …
  • 13
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology